JP7298601B2 - oral composition - Google Patents

oral composition Download PDF

Info

Publication number
JP7298601B2
JP7298601B2 JP2020522204A JP2020522204A JP7298601B2 JP 7298601 B2 JP7298601 B2 JP 7298601B2 JP 2020522204 A JP2020522204 A JP 2020522204A JP 2020522204 A JP2020522204 A JP 2020522204A JP 7298601 B2 JP7298601 B2 JP 7298601B2
Authority
JP
Japan
Prior art keywords
copper
salts
oral composition
mass
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020522204A
Other languages
Japanese (ja)
Other versions
JPWO2019230707A1 (en
Inventor
浩 飯島
三四郎 成松
雅人 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of JPWO2019230707A1 publication Critical patent/JPWO2019230707A1/en
Application granted granted Critical
Publication of JP7298601B2 publication Critical patent/JP7298601B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23Sulfur; Selenium; Tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Description

本発明は、銅イオンを含有し、口腔バイオフィルム殺菌効果と共に口臭成分の発生抑制効果に優れ、口臭抑制用として好適な口腔用組成物に関する。 TECHNICAL FIELD The present invention relates to an oral cavity composition that contains copper ions, is excellent in the effect of suppressing the generation of halitosis components as well as the effect of sterilizing oral biofilms, and is suitable for suppressing halitosis.

従来、銅イオンを含む水溶性銅化合物の抗菌作用、消臭作用に着目し、口臭の予防を目的として水溶性銅化合物を口腔用組成物に配合した口腔用組成物が種々提案され、特許文献1(特許第2540892号公報)には、グルコン酸銅等の銅化合物と特定の殺菌剤とを併用し、抗菌効果と共に口臭除去効果の持続性が優れる口腔用組成物が提案されている。
また、水溶性銅化合物を用いた技術として、特許文献2(特開2011-105650号公報)は、口腔内に塗布して使用し得るゲル状口腔用組成物に水溶性銅化合物、フェノール系殺菌剤、界面活性剤等を配合することで、バイオフィルム抑制効果及びジンジパイン阻害効果が優れ、口腔内滞留性も高まり、歯周病改善に効果的であることを提案している。特許文献3(特開2003-192555号公報)は、特殊な研磨剤(特定の合成無定形ケイ酸塩)を銅化合物に併用した歯磨剤組成物が、長期保存後も口臭抑制効果に優れることを提案している。
しかしながら、口臭発生には様々な要因が複雑に関与していることもあり、口臭を満足に抑制することは難しく、特に歯周病罹患者に対する口臭抑制効果は必ずしも十分ではなかった。
Conventionally, focusing on the antibacterial action and deodorizing action of a water-soluble copper compound containing copper ions, various oral compositions containing a water-soluble copper compound added to oral compositions for the purpose of preventing bad breath have been proposed. 1 (Japanese Patent No. 2540892) proposes an oral cavity composition that uses a copper compound such as copper gluconate in combination with a specific bactericidal agent, and has an excellent antibacterial effect and a long lasting bad breath removing effect.
In addition, as a technique using a water-soluble copper compound, Patent Document 2 (Japanese Patent Application Laid-Open No. 2011-105650) discloses a gel-like oral composition that can be applied and used in the oral cavity, a water-soluble copper compound, and a phenolic sterilizer. By blending agents, surfactants, etc., it is proposed that the biofilm inhibitory effect and gingipain inhibitory effect are excellent, the retention in the oral cavity is enhanced, and it is effective in improving periodontal disease. Patent Document 3 (Japanese Patent Application Laid-Open No. 2003-192555) describes that a dentifrice composition in which a special abrasive (specific synthetic amorphous silicate) is used in combination with a copper compound has an excellent bad breath suppressing effect even after long-term storage. is proposing.
However, since various factors are involved in the development of halitosis in a complex manner, it is difficult to satisfactorily suppress halitosis.

ところで、歯周病の原因となる病原性細菌は、口腔内に強固なバイオフィルムを形成して生息しており、このバイオフィルムの浸透殺菌にイソプロピルメチルフェノール等のノニオン性殺菌剤が有効であることは知られている(特許文献4;特開2011-98916号公報)が、バイオフィルムを殺菌するだけでは口臭を満足に抑制できなかった。 By the way, pathogenic bacteria that cause periodontal disease live in the oral cavity forming a strong biofilm, and nonionic bactericides such as isopropylmethylphenol are effective in penetrating and sterilizing this biofilm. Although it is known (Patent Document 4; Japanese Patent Application Laid-Open No. 2011-98916), bad breath could not be suppressed satisfactorily just by sterilizing biofilms.

特許第2540892号公報Japanese Patent No. 2540892 特開2011-105650号公報JP 2011-105650 A 特開2003-192555号公報JP 2003-192555 A 特開2011-98916号公報JP 2011-98916 A

本発明は、上記事情に鑑みなされたもので、銅イオンを含有し、口腔バイオフィルム殺菌効果と共に口臭成分の発生抑制効果に優れ、口臭抑制用として好適な口腔用組成物を提供することを目的とする。 The present invention has been made in view of the above circumstances, and an object of the present invention is to provide an oral composition that contains copper ions, is excellent in the effect of suppressing the generation of halitosis components as well as the effect of sterilizing oral biofilms, and is suitable for suppressing halitosis. and

本発明者らは、上記目的を達成するため鋭意検討を行った結果、特定量の銅イオンにノニオン性殺菌剤と特定のアニオン性界面活性剤とを組み合わせて口腔用組成物に配合すると、口腔バイオフィルム殺菌効果に加えて口臭成分、特にメチルメルカプタンの発生を抑制する優れた作用効果を奏することを知見した。即ち、本発明では、(A)銅イオンを0.001~0.2質量%、(B)ノニオン性殺菌剤を0.01~1質量%、(C)アシルタウリン、アシルアミノ酸及びこれらの塩から選ばれる1種又は2種以上のアニオン性界面活性剤を0.1~2質量%含有する口腔用組成物が、口腔バイオフィルムの殺菌効果と共に口臭成分の発生抑制効果に優れ、バイオフィルムが形成されていても、口臭原因菌からの口臭成分の発生を長時間に亘って抑制し、また、味も良く、特に口臭の抑制又は除去用として有効であることを知見し、本発明をなすに至った。 The present inventors have made intensive studies to achieve the above objects, and found that when a specific amount of copper ions, a nonionic bactericide and a specific anionic surfactant are combined and blended into an oral composition, the oral cavity It was found that in addition to the biofilm sterilization effect, an excellent effect of suppressing the generation of bad breath components, especially methyl mercaptan, is exhibited. That is, in the present invention, (A) 0.001 to 0.2% by mass of copper ion, (B) 0.01 to 1% by mass of nonionic fungicide, (C) acyl taurine, acyl amino acid and salts thereof An oral composition containing 0.1 to 2% by mass of one or more anionic surfactants selected from is excellent in the effect of suppressing the generation of halitosis components as well as the bactericidal effect of oral biofilms, and biofilms Even if it is formed, it suppresses the generation of halitosis components from halitosis-causing bacteria for a long time, has a good taste, and has found that it is particularly effective for suppressing or removing halitosis, and made the present invention. reached.

更に詳述すると、本発明者らが、特に歯周病罹患者における口臭予防をケアすることを目標に検討を行ったところ、銅イオンによる口臭抑制効果は十分ではなく、口腔用組成物に銅イオンを配合しただけでは口臭が満足に抑制されなかった。そこで、歯周病罹患者に多い傾向にあるバイオフィルムに着目し、バイオフィルム中の口臭原因菌が出す口臭成分が主な原因となっているのではないかと推定し、バイオフィルムからの口臭成分の発生抑制を目指して更に検討を進めた。その結果、(A)成分に(B)及び(C)成分をそれぞれ適切量で組み合わせて口腔用組成物、特に歯磨剤組成物に配合すると、三者が相乗的に作用して、意外にも口臭成分の発生抑制作用が増強して発現し、これにより、バイオフィルム殺菌効果と共に、口臭原因菌がバイオフィルムを形成して生息していても口臭成分、特にメチルメルカプタンの発生を長時間に亘って抑制する優れた作用効果を付与できた。したがって、本発明によれば、バイオフィルムの殺菌だけでは抑制することが困難であった歯周病罹患者の口臭をも効果的に抑制又は除去することが可能である。
本発明では、(A)、(B)及び(C)成分の組み合わせによって、上記格別な作用効果を与えることができたものであり、後述の比較例にも示すように、(A)、(B)及び(C)成分のうちのいずれかの成分を欠くと、メチルメルカプタン発生抑制効果が悪く、作用効果が劣った(比較例1~5)。一方、(A)、(B)成分が配合され、更にアニオン性界面活性剤のラウリル硫酸ナトリウムが配合されていても、(C)成分が配合されていないと、メチルメルカプタン発生抑制効果が劣った(比較例6)。
なお、特許文献1は、銅化合物及び殺菌剤による抗菌及び口臭の持続的抑制であるがバイオフィルムに対する効果は検討されておらず不明である。特許文献2は、ゲル状口腔用組成物における、水溶性銅化合物のジンジパイン阻害作用とフェノール系殺菌剤のバイオフィルム浸透殺菌効果との向上、それによる歯周病の抑制である。特許文献3は、歯磨組成物の研磨剤として特殊な合成無定形ケイ酸塩による銅化合物の口臭抑制効果の改善である。これらに対して、本発明は、(A)、(B)及び(C)成分の三者の組み合わせによる特異的な口腔バイオフィルムの殺菌及び口臭成分の発生抑制であり、口腔用組成物、特に練歯磨剤組成物において、格別顕著な作用効果を付与できたものである。
More specifically, the present inventors conducted a study with the goal of preventing bad breath in patients suffering from periodontal disease, and found that the effect of copper ions in suppressing bad breath was not sufficient. Bad breath was not satisfactorily suppressed only by adding ions. Therefore, we focused on biofilms, which tend to be common in patients with periodontal disease, and presumed that the main cause was the components of halitosis produced by the bacteria that cause halitosis in the biofilms. Further studies were carried out with the aim of suppressing the occurrence of As a result, when component (A) is combined with components (B) and (C) in appropriate amounts and blended into an oral composition, particularly a dentifrice composition, the three components act synergistically, unexpectedly The effect of suppressing the generation of halitosis components is enhanced, and as a result, along with the biofilm sterilization effect, the generation of halitosis components, especially methyl mercaptan, occurs over a long period of time even if halitosis-causing bacteria form biofilms and inhabit. It was possible to impart an excellent effect of suppressing Therefore, according to the present invention, it is possible to effectively suppress or eliminate bad breath in patients suffering from periodontal disease, which has been difficult to suppress only by biofilm sterilization.
In the present invention, the combination of the components (A), (B) and (C) was able to provide the above-mentioned special effects. When one of the components B) and (C) was lacking, the methyl mercaptan formation inhibitory effect was poor and the effect was inferior (Comparative Examples 1 to 5). On the other hand, even if the components (A) and (B) were blended and the anionic surfactant sodium lauryl sulfate was further blended, if the component (C) was not blended, the methyl mercaptan generation inhibitory effect was inferior. (Comparative Example 6).
In addition, Patent Document 1 describes antibacterial properties and continuous suppression of bad breath by a copper compound and a disinfectant, but the effect on biofilms has not been investigated and is unknown. Patent Document 2 is an improvement in the gingipain inhibitory effect of a water-soluble copper compound and the biofilm permeation sterilization effect of a phenolic fungicide in a gel-like oral composition, thereby suppressing periodontal disease. Patent document 3 is an improvement of the bad breath suppressing effect of a copper compound by using a special synthetic amorphous silicate as an abrasive for a dentifrice composition. In contrast to these, the present invention is a specific oral biofilm sterilization and suppression of halitosis components by a combination of the three components (A), (B) and (C), and oral compositions, particularly In the toothpaste composition, it was possible to impart particularly remarkable effects.

したがって、本発明は、下記の口腔用組成物を提供する。
〔1〕
(A)銅イオンを0.001~0.2質量%、
(B)ノニオン性殺菌剤を0.01~1質量%、及び
(C)アシルタウリン、アシルアミノ酸及びこれらの塩から選ばれる1種又は2種以上のアニオン性界面活性剤を0.1~2質量%
含有する口腔用組成物。
〔2〕
(A)銅イオン源が、グルコン酸銅、クエン酸銅、硫酸銅及び塩化銅から選ばれる1種又は2種以上の水溶性銅化合物である〔1〕に記載の口腔用組成物。
〔3〕
(B)ノニオン性殺菌剤が、イソプロピルメチルフェノールである〔1〕又は〔2〕に記載の口腔用組成物。
〔4〕
アシルタウリン、アシルアミノ酸が、それぞれ炭素数8~18のアシル基を有するものである〔1〕~〔3〕のいずれかに記載の口腔用組成物。
〔5〕
(C)成分が、アシルタウリン及びその塩から選ばれる〔1〕~〔4〕のいずれかに記載の口腔用組成物。
〔6〕
(C)成分が、ラウロイルメチルタウリンナトリウムである〔5〕に記載の口腔用組成物。
〔7〕
更に、(D)炭素数10以下の有機酸及びその塩から選ばれる1種又は2種以上を0.01~3質量%含有する〔1〕~〔6〕のいずれかに記載の口腔用組成物。
〔8〕
シリカ系研磨剤含有の練歯磨剤組成物である〔1〕~〔7〕のいずれかに記載の口腔用組成物。
〔9〕
口臭抑制及び口腔バイオフィルム殺菌用である〔1〕~〔8〕のいずれかに記載の口腔用組成物。
Accordingly, the present invention provides the following oral compositions.
[1]
(A) 0.001 to 0.2% by mass of copper ions,
(B) 0.01 to 1% by mass of a nonionic fungicide, and (C) 0.1 to 2 of one or more anionic surfactants selected from acyl taurine, acylamino acids and salts thereof mass%
Oral composition containing.
[2]
(A) The oral composition according to [1], wherein the copper ion source is one or more water-soluble copper compounds selected from copper gluconate, copper citrate, copper sulfate and copper chloride.
[3]
(B) The oral cavity composition according to [1] or [2], wherein the nonionic disinfectant is isopropylmethylphenol.
[4]
The oral composition according to any one of [1] to [3], wherein the acyl taurine and the acyl amino acid each have an acyl group of 8 to 18 carbon atoms.
[5]
The oral composition according to any one of [1] to [4], wherein component (C) is selected from acyl taurine and salts thereof.
[6]
(C) The oral composition according to [5], wherein the component is sodium lauroylmethyltaurate.
[7]
The oral cavity composition according to any one of [1] to [6], further containing (D) 0.01 to 3% by mass of one or more selected from organic acids having 10 or less carbon atoms and salts thereof. thing.
[8]
The oral composition according to any one of [1] to [7], which is a toothpaste composition containing a silica-based abrasive.
[9]
The oral cavity composition according to any one of [1] to [8], which is for bad breath suppression and oral biofilm sterilization.

本発明によれば、銅イオンを含有し、口腔バイオフィルム殺菌効果と共に口臭成分の発生抑制効果に優れ、口臭抑制用として好適な口腔用組成物を提供できる。この口腔用組成物は、歯周病罹患者の口臭抑制又は除去にも有効に使用することができる。 According to the present invention, it is possible to provide an oral composition that contains copper ions, is excellent in the effect of suppressing the generation of halitosis components as well as the effect of sterilizing oral biofilms, and is suitable for suppressing halitosis. This oral composition can also be effectively used to suppress or eliminate bad breath in patients suffering from periodontal disease.

以下、本発明につき更に詳述する。本発明の口腔用組成物は、(A)銅イオン、(B)ノニオン性殺菌剤、及び(C)特定のアニオン性界面活性剤を含有する。
ここで、「銅イオン」は、組成物の液体媒体(水等)中に溶解している銅化合物の銅イオンを意味し、組成物中に固体状で存在する不溶の銅化合物ではない。
The present invention will be described in further detail below. The oral composition of the present invention contains (A) copper ions, (B) a nonionic germicide, and (C) a specific anionic surfactant.
As used herein, "copper ion" means the copper ion of a copper compound that is dissolved in the liquid medium (such as water) of the composition, and not the insoluble copper compound present in the composition in solid form.

(A)銅イオンは、口臭の抑制又は除去剤であり、口臭成分であるメチルメルカプタンの発生抑制剤として作用する。
銅イオン源となる銅含有化合物は、水溶性銅化合物であることが好ましい。水溶性銅化合物は、25℃における水溶解度が5g/100mL以上の化合物であり、グルコン酸銅、クエン酸銅、硫酸銅、塩化銅等の水溶性の銅塩が好ましく、より好ましくはグルコン酸銅、クエン酸銅、硫酸銅、とりわけグルコン酸銅、クエン酸銅である。これらは、1種単独でも2種以上を併用してもよい。
(A)成分は、他の態様として、25℃における水への溶解度が5g/100mL未満の水難溶性又は不溶性の銅化合物を他の溶媒に溶解した溶液由来の銅イオンを使用することもでき、上記溶液をイオンの供給源として使用し配合することもできる。例えば、水不溶性の酸化銅を希塩酸等の酸性水溶液に溶解して得られた銅イオンを使用することもできる。また、金属錯体を形成させて系中に溶解させた銅含有化合物の銅、界面活性剤を用いて可溶化させた銅含有化合物の銅も、本発明の銅イオンとすることができる。
(A) Copper ion is an agent for suppressing or removing bad breath, and acts as an agent for suppressing generation of methyl mercaptan, which is a bad breath component.
The copper-containing compound that serves as the copper ion source is preferably a water-soluble copper compound. The water-soluble copper compound is a compound having a water solubility of 5 g/100 mL or more at 25° C., and is preferably a water-soluble copper salt such as copper gluconate, copper citrate, copper sulfate, or copper chloride, more preferably copper gluconate. , copper citrate, copper sulfate, especially copper gluconate, copper citrate. These may be used singly or in combination of two or more.
As another aspect, the component (A) is a copper ion derived from a solution of a poorly water-soluble or insoluble copper compound with a water solubility of less than 5 g / 100 mL at 25 ° C. dissolved in another solvent. The above solution can also be used as a source of ions and formulated. For example, copper ions obtained by dissolving water-insoluble copper oxide in an acidic aqueous solution such as dilute hydrochloric acid can also be used. In addition, copper in a copper-containing compound formed by forming a metal complex and dissolved in the system, and copper in a copper-containing compound solubilized using a surfactant can be used as the copper ion of the present invention.

(A)銅イオンの配合量は、組成物全体の0.001~0.2%(質量%、以下同様)、好ましくは0.005~0.15%であり、より好ましくは0.01~0.1%である。0.001%以上であると、十分な口臭除去効果が発現すると共にメチルメルカプタン発生抑制効果が発現する。0.2%を超えると、銅の金属味が増強して抑制が困難になり製剤の味が悪くなる。また、保存後の製剤安定性(液分離のなさ、変色のなさ)が劣ることがある。 (A) The content of copper ions is 0.001 to 0.2% (% by mass, the same shall apply hereinafter) of the total composition, preferably 0.005 to 0.15%, more preferably 0.01 to 0.1%. When it is 0.001% or more, sufficient bad breath removing effect is exhibited and methyl mercaptan generation suppressing effect is exhibited. If it exceeds 0.2%, the metallic taste of copper is enhanced and difficult to suppress, resulting in a bad taste of the preparation. In addition, the formulation stability after storage (no liquid separation, no discoloration) may be inferior.

(B)ノニオン性殺菌剤は、バイオフィルム殺菌作用を奏すると共に、口臭成分であるメチルメルカプタンの発生抑制剤として作用する。
ノニオン性殺菌剤は、イソプロピルメチルフェノール、トリクロサンが好ましく、より好ましくはイソプロピルメチルフェノール(3-メチル-4-イソプロピルフェノール)である。
(B)ノニオン性殺菌剤の配合量は、組成物全体の0.01~1%であり、好ましくは0.05~0.5%である。0.01%未満では、十分なバイオフィルム殺菌効果及びメチルメルカプタン発生抑制効果が劣る。上限量は特に限定されないが、1%以下であると製剤に十分に溶解し、1%を超えると溶解性が低下して作用が劣ることがある。
(B) The nonionic fungicide exhibits a biofilm sterilization effect and acts as an inhibitor of generation of methyl mercaptan, which is a bad breath component.
The nonionic fungicide is preferably isopropylmethylphenol, triclosan, more preferably isopropylmethylphenol (3-methyl-4-isopropylphenol).
The amount of (B) nonionic fungicide is 0.01 to 1%, preferably 0.05 to 0.5%, of the total composition. If it is less than 0.01%, sufficient biofilm sterilization effect and methyl mercaptan generation suppression effect are inferior. The upper limit of the amount is not particularly limited, but if it is 1% or less, it will be sufficiently dissolved in the formulation, and if it exceeds 1%, the solubility may decrease and the action may be inferior.

(C)成分は、アシルタウリン、アシルアミノ酸及びこれらの塩から選ばれる1種又は2種以上のアニオン性界面活性剤である。(C)成分は、口臭成分であるメチルメルカプタンの発生抑制剤として作用する。また、(B)成分によるバイオフィルム殺菌作用の向上にも寄与する。(C)成分としては、上記作用効果の点から、特にアシルタウリン及びその塩から選ばれるものが好ましい。
(C)成分は、好ましくはアシル基の炭素数が8~18、特に12~16であり、前記アシル基を有するアシルタウリン塩、アシルアミノ酸塩から選ばれ、アシルアミノ酸塩としては、特にアシルサルコシン塩が好適である。中でも、ラウロイルメチルタウリン塩、ラウロイルサルコシン塩、とりわけラウロイルメチルタウリン塩が好ましい。また、これらの塩は、アルカリ金属塩、アルカリ土類金属塩、有機アミン塩等であり、中でもアルカリ金属塩、特にナトリウム塩が好ましい。
Component (C) is one or more anionic surfactants selected from acyl taurine, acyl amino acids and salts thereof. The component (C) acts as an inhibitor of generation of methyl mercaptan, which is a bad breath component. Moreover, it also contributes to the improvement of the biofilm bactericidal action by the component (B). As the component (C), those selected from acyl taurine and salts thereof are particularly preferable from the viewpoint of the above effects.
Component (C) preferably has an acyl group with 8 to 18 carbon atoms, particularly 12 to 16 carbon atoms, and is selected from acyl taurine salts and acyl amino acid salts having the acyl group. Salt is preferred. Among them, lauroyl methyl taurate, lauroyl sarcosine, and particularly lauroyl methyl taurate are preferred. These salts are alkali metal salts, alkaline earth metal salts, organic amine salts, etc. Among them, alkali metal salts, particularly sodium salts are preferred.

アシルタウリン塩としては、例えばラウロイルメチルタウリンナトリウム、ミリストイルメチルタウリンナトリウム、ヤシ油脂肪酸メチルタウリンナトリウム等が挙げられる。
アシルアミノ酸塩としては、例えばラウロイルサルコシンナトリウム、ラウロイルグルタミン酸ナトリウム、ラウロイルアスパラギン酸ナトリウム等が挙げられる。
これらは市販品を使用でき、具体的には、NIKKOL LMT(ラウロイルメチルタウリンナトリウム、日光ケミカルズ(株)製)、NIKKOL MMT(ミリストイルメチルタウリンナトリウム、日光ケミカルズ(株)製)、ソイポンSLP(ラウロイルサルコシンナトリウム、川研ファインケミカル(株)製)、アミソフトLS-11(ラウロイルグルタミン酸ナトリウム、味の素ヘルシーサプライ(株)製)等を使用できる。
Examples of acyl taurine salts include sodium lauroyl methyl taurate, sodium myristoyl methyl taurate, and sodium methyl taurate of coconut oil fatty acid.
Examples of acyl amino acid salts include sodium lauroyl sarcosinate, sodium lauroyl glutamate, sodium lauroyl aspartate and the like.
Commercially available products can be used, specifically, NIKKOL LMT (sodium lauroyl methyl taurate, manufactured by Nikko Chemicals Co., Ltd.), NIKKOL MMT (sodium myristoyl methyl taurate, manufactured by Nikko Chemicals Co., Ltd.), Soypon SLP (lauroyl sarcosine) Sodium, manufactured by Kawaken Fine Chemicals Co., Ltd.), Amisoft LS-11 (sodium lauroyl glutamate, manufactured by Ajinomoto Healthy Supply Co., Ltd.), and the like can be used.

(C)成分の配合量は、組成物全体の0.1~2%、好ましくは0.3~1.5%である。配合量が0.1%未満では、メチルメルカプタン発生抑制効果が十分に得られず、また、バイオフィルム殺菌効果が低くなる傾向にある。2%を超えると、(A)成分由来の銅の金属味が強くなり、製剤の味が低下する。 The content of component (C) is 0.1-2%, preferably 0.3-1.5%, of the total composition. If the compounding amount is less than 0.1%, the effect of inhibiting generation of methyl mercaptan cannot be sufficiently obtained, and the effect of biofilm sterilization tends to decrease. If it exceeds 2%, the copper derived from the component (A) has a strong metallic taste, and the taste of the preparation deteriorates.

なお、本発明では、上記(C)成分以外のアニオン性界面活性剤は、本発明の効果を妨げない範囲であれば配合してもよいが、特にラウリル硫酸ナトリウム等のアルキル硫酸塩は配合しない(配合量0%)ほうがよく、配合する場合は組成物全体の0.5%以下、特に0.2%以下、とりわけ0.1%以下の量がよい。 In the present invention, anionic surfactants other than the above component (C) may be blended as long as they do not interfere with the effects of the present invention, but alkyl sulfates such as sodium lauryl sulfate are not particularly blended. (0% compounded amount) is better, and when compounded, the amount is preferably 0.5% or less, particularly 0.2% or less, and especially 0.1% or less based on the total composition.

本発明の口腔用組成物には、更に、(D)炭素数10以下の有機酸又はその塩を配合することが好ましい。(D)成分を配合すると、(A)成分由来の銅による金属味が改善して製剤の味がより優れる。
有機酸は炭素数10以下、好ましくは4~6であり、前記炭素数のトリカルボン酸、ジカルボン酸やこれらの塩を用いることができ、塩はアルカリ金属塩である。中でも、ヒドロキシ酸であるクエン酸、酒石酸、リンゴ酸やこれらの塩が好ましい。これらは、1種単独でも2種以上を併用してもよい。
The oral composition of the present invention preferably further contains (D) an organic acid having 10 or less carbon atoms or a salt thereof. When the component (D) is blended, the metallic taste due to the copper derived from the component (A) is improved and the taste of the formulation is more excellent.
The organic acid has 10 or less carbon atoms, preferably 4 to 6 carbon atoms, and tricarboxylic acids, dicarboxylic acids, and salts thereof having the above carbon atoms can be used, and the salts are alkali metal salts. Among them, hydroxy acids such as citric acid, tartaric acid, malic acid, and salts thereof are preferred. These may be used singly or in combination of two or more.

(D)成分の配合量は、組成物全体の0.01~3%が好ましく、0.1~2%がより好ましい。この範囲内であると、味の改善効果がより優れ、かつ十分なメチルメルカプタン発生抑制効果が発揮される。 The content of component (D) is preferably 0.01 to 3%, more preferably 0.1 to 2%, of the total composition. Within this range, the effect of improving the taste is more excellent, and a sufficient effect of suppressing the generation of methyl mercaptan is exhibited.

本発明の口腔用組成物は、特に練歯磨、液状歯磨、潤製歯磨等の歯磨剤組成物、とりわけ練歯磨剤組成物として好適であり、上記成分に加えて、これら以外の公知成分を本発明の効果を妨げない範囲で必要に応じて配合できる。具体的には、研磨剤、湿潤剤、粘結剤、アニオン性界面活性剤以外の界面活性剤、更に必要により甘味剤、着色剤、防腐剤、香料、銅イオン源となる化合物及びノニオン性殺菌剤以外の有効成分を配合できる。 The oral composition of the present invention is particularly suitable as a dentifrice composition such as a toothpaste, a liquid dentifrice, and a wet dentifrice, especially as a dentifrice composition. It can be blended according to need within a range that does not interfere with the effects of the invention. Specifically, abrasives, wetting agents, binding agents, surfactants other than anionic surfactants, sweeteners, coloring agents, preservatives, fragrances, compounds that serve as a source of copper ions, and nonionic sterilization if necessary. Active ingredients other than the agent can be blended.

研磨剤は、口腔用として一般的な研磨剤を用いることができる。例えば、沈降性シリカ、火成性シリカといった無水ケイ酸、アルミノシリケート、ジルコノシリケート、チタン結合性シリカ等のシリカ系研磨剤、第2リン酸カルシウム・2水和物又は無水和物、第1リン酸カルシウム、第3リン酸カルシウム等のリン酸カルシウム系研磨剤、炭酸カルシウム、水酸化カルシウム、水酸化アルミニウム、不溶性メタリン酸ナトリウム、合成樹脂系研磨剤が挙げられ、歯磨剤用として一般的なシリカ系研磨剤が好適である。これら研磨剤の配合量は、通常、2~40%、特に10~30%である。 Abrasives that are commonly used for the oral cavity can be used. For example, silicic anhydride such as precipitated silica and igneous silica, silica-based abrasives such as aluminosilicate, zirconosilicate and titanium-bonded silica, dicalcium phosphate dihydrate or anhydrate, monocalcium phosphate, Calcium phosphate-based abrasives such as tribasic calcium phosphate, calcium carbonate, calcium hydroxide, aluminum hydroxide, insoluble sodium metaphosphate, and synthetic resin-based abrasives can be mentioned, and silica-based abrasives generally used for dentifrices are suitable. . The blending amount of these abrasives is usually 2 to 40%, particularly 10 to 30%.

湿潤剤は、ソルビット、キシリット等の糖アルコール、グリセリン、プロピレングリコール等の多価アルコールが挙げられる。湿潤剤の配合量は、通常、5~50%、特に10~40%である。 Wetting agents include sugar alcohols such as sorbitol and xylite, and polyhydric alcohols such as glycerin and propylene glycol. The amount of wetting agent is usually 5-50%, especially 10-40%.

粘結剤は、有機粘結剤、無機粘結剤を使用できる。有機粘結剤としては、カルボキシメチルセルロースナトリウム、メチルセルロース、ヒドロキシメチルセルロース、ヒドロキシエチルセルロース等のセルロース誘導体、キサンタンガム等のガム類、アルギン酸ナトリウム等のアルギン酸誘導体、カラギーナン、ポリビニルアルコール、ポリアクリル酸ナトリウムが挙げられる。無機粘結剤としては、ゲル化性シリカ、ゲル化性アルミニウムシリカ等が挙げられる。
粘結剤の配合量は、通常、0.1~10%、特に0.2~8%であり、有機粘結剤の配合量は0.1~5%、特に0.5~3%がよく、無機粘結剤の配合量は0.1~8%、特に0.5~5%がよい。
As the binder, an organic binder or an inorganic binder can be used. Examples of organic binders include cellulose derivatives such as sodium carboxymethylcellulose, methylcellulose, hydroxymethylcellulose, and hydroxyethylcellulose, gums such as xanthan gum, alginic acid derivatives such as sodium alginate, carrageenan, polyvinyl alcohol, and sodium polyacrylate. Examples of inorganic binders include gelling silica and gelling aluminum silica.
The amount of the binder is usually 0.1-10%, especially 0.2-8%, and the amount of the organic binder is 0.1-5%, especially 0.5-3%. The content of the inorganic binder is often 0.1 to 8%, preferably 0.5 to 5%.

界面活性剤は、ノニオン性界面活性剤、カチオン性界面活性剤、両性界面活性剤を任意に配合できる。具体的にノニオン性界面活性剤は、ショ糖脂肪酸エステル等の糖脂肪酸エステル、糖アルコール脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油等のポリオキシエチレン脂肪酸エステル、ポリオキシエチレンステアリルエーテル等のポリオキシエチレン高級アルコールエーテル、ラウリン酸ジエタノールアミド等の脂肪酸アルカノールアミドが挙げられる。カチオン性界面活性剤は、塩化ジステアリルメチルアンモニウム等のアルキルアンモニウム型、アルキルベンジルアンモニウム塩が挙げられる。両性界面活性剤は、アルキルベタインや、アルキルジメチルアミノ酢酸ベタイン、脂肪酸アミドプロピルベタイン等の酢酸ベタイン型、アルキルイミダゾリニウムベタイン等のベタイン型、イミダゾリン型が挙げられる。これら界面活性剤の配合量は、0~10%、特に0.01~5%がよい。ノニオン性界面活性剤は、配合量が0.01%以下でもよく、配合せず0%でもよい。 A nonionic surfactant, a cationic surfactant, or an amphoteric surfactant can be arbitrarily blended as the surfactant. Specifically, nonionic surfactants include sugar fatty acid esters such as sucrose fatty acid esters, sugar alcohol fatty acid esters, glycerin fatty acid esters, polyglycerin fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene hydrogenated castor oils and the like. Examples include oxyethylene fatty acid esters, polyoxyethylene higher alcohol ethers such as polyoxyethylene stearyl ether, and fatty acid alkanolamides such as lauric acid diethanolamide. Examples of cationic surfactants include alkylammonium types such as distearylmethylammonium chloride and alkylbenzylammonium salts. Amphoteric surfactants include alkylbetaines, betaine acetate types such as alkyldimethylaminoacetic acid betaine and fatty acid amidopropyl betaine, betaine types such as alkylimidazolinium betaine, and imidazoline types. The blending amount of these surfactants is preferably 0 to 10%, particularly 0.01 to 5%. The nonionic surfactant may be blended in an amount of 0.01% or less, or not blended at 0%.

甘味剤は、サッカリンナトリウム等、着色剤は、青色1号、黄色4号、二酸化チタン等が挙げられる。防腐剤は、パラオキシ安息香酸メチル等のパラオキシ安息香酸エステル、安息香酸又はその塩が挙げられる。 Examples of sweetening agents include sodium saccharin, and examples of coloring agents include Blue No. 1, Yellow No. 4, titanium dioxide and the like. Preservatives include paraoxybenzoic acid esters such as methyl parahydroxybenzoate, benzoic acid, and salts thereof.

香料は、ペパーミント油、スペアミント油、アニス油、ユーカリ油、ウィンターグリーン油、カシア油、クローブ油、タイム油、セージ油、レモン油、オレンジ油、ハッカ油、カルダモン油、コリアンダー油、マンダリン油、ライム油、ラベンダー油、ローズマリー油、ローレル油、カモミル油、キャラウェイ油、マジョラム油、ベイ油、レモングラス油、オリガナム油、パインニードル油、ネロリ油、ローズ油、ジャスミン油、グレープフルーツ油、スウィーティー油、柚油、イリスコンクリート、アブソリュートペパーミント、アブソリュートローズ、オレンジフラワー等の天然香料や、これら天然香料の加工処理(前溜部カット、後溜部カット、分留、液液抽出、エッセンス化、粉末香料化等)した香料、及び、メントール、カルボン、アネトール、シネオール、サリチル酸メチル、シンナミックアルデヒド、オイゲノール、3-l-メントキシプロパン-1,2-ジオール、チモール、リナロール、リナリールアセテート、リモネン、メントン、メンチルアセテート、N-置換-パラメンタン-3-カルボキサミド、ピネン、オクチルアルデヒド、シトラール、プレゴン、カルビールアセテート、アニスアルデヒド、エチルアセテート、エチルブチレート、アリルシクロヘキサンプロピオネート、メチルアンスラニレート、エチルメチルフェニルグリシデート、バニリン、ウンデカラクトン、ヘキサナール、ブタノール、イソアミルアルコール、ヘキセノール、ジメチルサルファイド、シクロテン、フルフラール、トリメチルピラジン、エチルラクテート、エチルチオアセテート等の単品香料、更に、ストロベリーフレーバー、アップルフレーバー、バナナフレーバー、パイナップルフレーバー、グレープフレーバー、マンゴーフレーバー、バターフレーバー、ミルクフレーバー、フルーツミックスフレーバー、トロピカルフルーツフレーバー等の調合香料等が挙げられ、口腔用組成物に用いられる公知の香料素材を組み合わせて使用することができる。
上記の香料素材の配合量は、0.000001~1%が好ましく、上記香料素材を使用した賦香用香料の配合量は、0.1~2%が好ましい。
Peppermint oil, spearmint oil, anise oil, eucalyptus oil, wintergreen oil, cassia oil, clove oil, thyme oil, sage oil, lemon oil, orange oil, peppermint oil, cardamom oil, coriander oil, mandarin oil, lime. Oil, Lavender Oil, Rosemary Oil, Laurel Oil, Chamomile Oil, Caraway Oil, Marjoram Oil, Bay Oil, Lemongrass Oil, Origanum Oil, Pine Needle Oil, Neroli Oil, Rose Oil, Jasmine Oil, Grapefruit Oil, Sweetie Oil , Yuzu Oil, Iris Concrete, Absolute Peppermint, Absolute Rose, Orange Flower, etc., and processing of these natural flavors (pre-reservoir cut, post-reservoir cut, fractional distillation, liquid-liquid extraction, essence formation, powder perfume ), and menthol, carvone, anethole, cineol, methyl salicylate, cinnamic aldehyde, eugenol, 3-l-menthoxypropane-1,2-diol, thymol, linalool, linalyl acetate, limonene, menthone , menthyl acetate, N-substituted-paramenthane-3-carboxamide, pinene, octylaldehyde, citral, pulegone, carbyl acetate, anisaldehyde, ethyl acetate, ethyl butyrate, allyl cyclohexane propionate, methyl anthranilate, ethyl methyl Phenyl glycidate, vanillin, undecalactone, hexanal, butanol, isoamyl alcohol, hexenol, dimethyl sulfide, cyclotene, furfural, trimethylpyrazine, ethyl lactate, ethyl thioacetate, etc., strawberry flavor, apple flavor, banana flavor , pineapple flavor, grape flavor, mango flavor, butter flavor, milk flavor, mixed fruit flavor, and tropical fruit flavor. can.
The blending amount of the above perfume material is preferably 0.000001 to 1%, and the blending amount of the perfume for perfuming using the above perfume material is preferably 0.1 to 2%.

有効成分は、塩化セチルピリジニウム、塩化ベンザルコニウム等のカチオン性殺菌剤、トラネキサム酸、イプシロンアミノカプロン酸、アラントイン等の抗炎症剤、デキストラナーゼ等の酵素、フッ化ナトリウム、モノフルオロリン酸ナトリウム等のフッ素含有化合物、アスコルビン酸、トコフェロール酢酸エステル等のビタミン類、グリチルリチン酸ジカリウム、硝酸カリウム、乳酸アルミニウム、塩化ナトリウム、タイム等の植物抽出物が挙げられる。上記任意の有効成分は、本発明の効果を妨げない範囲で有効量配合できる。 Active ingredients include cationic fungicides such as cetylpyridinium chloride and benzalkonium chloride, anti-inflammatory agents such as tranexamic acid, epsilon aminocaproic acid, and allantoin, enzymes such as dextranase, sodium fluoride, and sodium monofluorophosphate. vitamins such as ascorbic acid and tocopherol acetate, and plant extracts such as dipotassium glycyrrhizinate, potassium nitrate, aluminum lactate, sodium chloride and thyme. Any of the above active ingredients can be incorporated in an effective amount within a range that does not interfere with the effects of the present invention.

以下、実施例及び比較例を示し、本発明を具体的に説明するが、本発明は下記の実施例に制限されるものではない。なお、下記の例において%は特に断らない限りいずれも質量%を示す。 EXAMPLES The present invention will be specifically described below by showing examples and comparative examples, but the present invention is not limited to the following examples. In the following examples, % indicates % by mass unless otherwise specified.

[実施例、比較例]
表1~3に示す組成の練歯磨剤組成物を常法によって調製し、下記方法で評価した。結果を表に併記した。
[Examples, Comparative Examples]
Toothpaste compositions having the compositions shown in Tables 1 to 3 were prepared by conventional methods and evaluated by the following methods. The results are also shown in the table.

(1)バイオフィルム殺菌効果の評価方法
口腔細菌として、アクチノマイセス ヴィスコサス(Actinomyces viscosus)ATCC43146、フゾバクテリウム ヌクレアタム(Fusobacterium nucleatum)ATCC10953、ポルフィロモナス ジンジバリス(Porphyromonas gingivalis)ATCC33277は、5mg/Lのヘミン(Sigma社製)及び1mg/LのビタミンK(和光純薬工業(株)製)を含むトッドへヴィットブロス(Becton and Dickinson社製)培養液〔THBHM〕を用いて培養した。ベイヨネラ パルビュラ(Veillonella parvula)ATCC17745は、1.26%乳酸ナトリウム(Sigma社製)を含むトッドへヴィットブロス(Becton and Dickinson社製)培養液〔THBL〕を用いて培養した。なお、培養は、37℃で一晩嫌気培養(80vol%窒素、10vol%二酸化炭素、10vol%水素)した。培養後、菌液は遠心分離(8,000g×10min)により集菌した。遠心集菌した各細菌は、ベイサルメディウムムチン培養液(BMM)*1に再懸濁した。
直径7mm×厚さ3.5mmのハイドロキシアパタイト(HA)板(旭光学工業(株)製)を0.45μmのフィルターでろ過したヒト無刺激唾液で処理したものをモデルバイオフィルム作製の担体に用い、24穴マルチプレート(住友ベークライト(株)製)の底部に設置した。これに、BMMで1×107cfu/mL(cfu:colony forming units)に調製した上記4菌株を播種し、37℃、嫌気条件下(80vol%窒素、10vol%二酸化炭素、10vol%水素)で6日間連続培養し、HA板表面に4菌種混合のモデルバイオフィルムを形成させた。
バイオフィルムを形成後、培養液を除去したバイオフィルム付着HA板に対し、試験製剤として各例の練歯磨剤組成物を蒸留水で3倍希釈した遠心上清を0.5mL作用させて3分間処置(コントロールはリン酸緩衝生理食塩水(PBS、和光純薬工業(株)製)を使用して同様に処置)し、1mLのPBSで6回洗浄した後、4mLの生理食塩水に移し、超音波ホモジナイザーでバイオフィルムを分散した。このバイオフィルム分散液を生理食塩水で10倍ずつ段階希釈し、血液寒天培地に50μL塗抹し、嫌気培養を1週間行い、生えてきたコロニー数を計測した。
コロニー数をコントロール(PBS処理)と比較し、下記基準によってバイオフィルム殺菌効果を評価した。
評価基準
◎:コロニー数が1/500未満
○:コロニー数が1/500以上1/100未満
×:コロニー数が1/100以上
(1) Evaluation method of biofilm bactericidal effect As oral bacteria, Actinomyces viscosus ATCC43146, Fusobacterium nucleatum ATCC10953, Porphyromonas gingivalis ATCC33277 , 5 mg/L hemin (Sigma (manufactured by Wako Pure Chemical Industries, Ltd.) and 1 mg/L of vitamin K (manufactured by Wako Pure Chemical Industries, Ltd.). Veillonella parvula ATCC17745 was cultured using Toddhewitt broth (Becton and Dickinson) broth [THBL] containing 1.26% sodium lactate (Sigma). The culturing was carried out overnight at 37° C. with anaerobic culture (80 vol % nitrogen, 10 vol % carbon dioxide, 10 vol % hydrogen). After culturing, the bacterial solution was collected by centrifugation (8,000 g×10 min). Each bacterium collected by centrifugation was resuspended in basal medium mucin medium (BMM) *1 .
A hydroxyapatite (HA) plate (manufactured by Asahi Optical Co., Ltd.) with a diameter of 7 mm and a thickness of 3.5 mm was treated with unstimulated human saliva filtered through a 0.45 μm filter, and used as a carrier for model biofilm production. , was placed on the bottom of a 24-well multiplate (manufactured by Sumitomo Bakelite Co., Ltd.). To this, the above 4 strains prepared to 1 × 10 7 cfu / mL (cfu: colony forming units) with BMM were inoculated, 37 ° C., under anaerobic conditions (80 vol% nitrogen, 10 vol% carbon dioxide, 10 vol% hydrogen) It was continuously cultured for 6 days to form a model biofilm of a mixture of 4 bacterial species on the surface of the HA plate.
After biofilm formation, 0.5 mL of the centrifugal supernatant obtained by diluting the toothpaste composition of each example 3-fold with distilled water as a test formulation was applied to the biofilm-adhered HA plate from which the culture medium was removed, for 3 minutes. Treatment (control was treated in the same way using phosphate buffered saline (PBS, manufactured by Wako Pure Chemical Industries, Ltd.)), washed 6 times with 1 mL of PBS, transferred to 4 mL of physiological saline, The biofilm was dispersed with an ultrasonic homogenizer. This biofilm dispersion was serially diluted 10-fold with physiological saline, 50 μL of each was smeared on a blood agar medium, anaerobic culture was performed for 1 week, and the number of grown colonies was counted.
The number of colonies was compared with the control (PBS treatment), and the biofilm bactericidal effect was evaluated according to the following criteria.
Evaluation criteria ◎: The number of colonies is less than 1/500 ○: The number of colonies is 1/500 or more and less than 1/100 ×: The number of colonies is 1/100 or more

*1;BMMの組成(1L中の質量で表す。)
プロテオースペプトン(Becton and Dickinson社製):
4g/L
トリプトン(Becton and Dickinson社製):
2g/L
イーストエキス(Becton and Dickinson社製):
2g/L
ムチン(Sigma社製): 5g/L
ヘミン(Sigma社製): 2.5mg/L
ビタミンK(和光純薬工業(株)製): 0.5mg/L
KCl(和光純薬工業(株)製): 1g/L
システイン(和光純薬工業(株)製): 0.2g/L
蒸留水: 残
(全量が1Lになるようにメスアップし、120℃で20分間オートクレ
ーブした。)
* 1; Composition of BMM (indicated by mass in 1 L)
Proteose peptone (manufactured by Becton and Dickinson):
4g/L
Tryptone (manufactured by Becton and Dickinson):
2g/L
Yeast extract (manufactured by Becton and Dickinson):
2g/L
Mucin (manufactured by Sigma): 5 g / L
Hemin (manufactured by Sigma): 2.5 mg/L
Vitamin K (manufactured by Wako Pure Chemical Industries, Ltd.): 0.5 mg / L
KCl (manufactured by Wako Pure Chemical Industries, Ltd.): 1 g / L
Cysteine (manufactured by Wako Pure Chemical Industries, Ltd.): 0.2 g / L
Distilled water: Remainder (filled up to 1 L and autoclaved at 120°C for 20 minutes)

(2)メチルメルカプタン発生抑制効果の評価方法
(1)と同様にしてモデルバイオフィルムを形成後、試験製剤として各例の練歯磨剤組成物を蒸留水で3倍希釈した遠心上清0.5mLを3分間作用させて処置(コントロールはPBSを使用して同様に処置)し、PBSで洗浄後、ガラス瓶に移し、メチオニン含有PBS溶液を添加して密封した。37℃でインキュベートし、3時間経過後の気相中のメチルメルカプタン(MeSH)量をガスクロマトグラフィーにて測定してその濃度を求めた。
メチルメルカプタン濃度をコントロール(PBS処理)と比較し、下記基準によってメチルメルカプタン発生抑制効果を評価した。
評価基準
◎:メチルメルカプタン濃度が1/10未満
○:メチルメルカプタン濃度が1/10以上1/4未満
△:メチルメルカプタン濃度が1/4以上1/2未満
×:メチルメルカプタン濃度が1/2以上
(2) Evaluation method of methyl mercaptan generation inhibitory effect After forming a model biofilm in the same manner as in (1), 0.5 mL of centrifugal supernatant obtained by diluting the toothpaste composition of each example 3 times with distilled water as a test formulation. for 3 minutes (controls were treated in the same way using PBS), washed with PBS, transferred to a glass bottle, added with a methionine-containing PBS solution, and sealed. After 3 hours of incubation at 37° C., the amount of methyl mercaptan (MeSH) in the gas phase was measured by gas chromatography to determine its concentration.
The methyl mercaptan concentration was compared with the control (PBS-treated), and the methyl mercaptan generation inhibitory effect was evaluated according to the following criteria.
Evaluation criteria ◎: Methyl mercaptan concentration is less than 1/10 ○: Methyl mercaptan concentration is 1/10 or more and less than 1/4 △: Methyl mercaptan concentration is 1/4 or more and less than 1/2 ×: Methyl mercaptan concentration is 1/2 or more

(3)製剤の味(苦味、金属味のなさ)の評価方法
被験者5人によって使用感(味)の評価を行った。歯ブラシ(クリニカアドバンテージハブラシ、4列コンパクトふつうタイプ、ライオン(株)製)に試験製剤1gをのせ、3分間歯みがきを行った。歯みがき中の味について下記の評点基準で判定した。5人の平均点を求め、下記の評価基準によって製剤の味(苦味、金属味のなさ)を評価した。
評点基準
5:非常によい
4:よい
3:どちらともいえない
2:よくない
1:非常によくない
評価基準
◎:5人の平均点が4点以上
○:5人の平均点が3.5点以上4点未満
△:5人の平均点が3点以上3.5点未満
×:5人の平均点が3点未満
(3) Method for evaluating taste of formulation (absence of bitterness and metallic taste) Five subjects evaluated usability (taste). 1 g of the test formulation was placed on a toothbrush (Clinica Advantage Toothbrush, 4-row compact regular type, manufactured by Lion Corporation) and brushed for 3 minutes. The taste during toothbrushing was judged according to the following rating criteria. The average score of 5 people was obtained, and the taste of the preparation (absence of bitterness and metallic taste) was evaluated according to the following evaluation criteria.
Rating criteria 5: Very good 4: Good 3: Neither good nor bad 2: Not good 1: Very bad Evaluation criteria ◎: Average score of 5 people is 4 points or more ○: Average score of 5 people is 3.5 3 points or more and less than 4 points △: Average score of 5 people is 3 points or more and less than 3.5 points ×: Average score of 5 people is less than 3 points

Figure 0007298601000001

*:不溶粉末(固形物)中の銅量。
Figure 0007298601000001

*: Amount of copper in insoluble powder (solid matter).

Figure 0007298601000002
Figure 0007298601000002

Figure 0007298601000003
Figure 0007298601000003

Claims (9)

(A)銅イオンを0.0050.1質量%、
(B)イソプロピルメチルフェノールを0.01~1質量%、並びに
(C)アシルタウリン及びその塩から選ばれる1種又は2種以上のアニオン性界面活性剤を0.31.5質量%
含有する口腔用組成物。
(A) 0.005 to 0.1 % by mass of copper ions,
(B) 0.01 to 1% by mass of isopropylmethylphenol , and
(C) 0.3 to 1.5 % by mass of one or more anionic surfactants selected from acyl taurine and salts thereof
Oral composition containing.
(A)銅イオン源が、グルコン酸銅、クエン酸銅、硫酸銅及び塩化銅から選ばれる1種又は2種以上の水溶性銅化合物である請求項1記載の口腔用組成物。 2. The oral composition according to claim 1, wherein (A) the copper ion source is one or more water-soluble copper compounds selected from copper gluconate, copper citrate, copper sulfate and copper chloride. (C)成分が、炭素数8~18のアシル基を有するアシルタウリン及びその塩から選ばれる1種又は2種以上のアニオン性界面活性剤である請求項1又は2記載の口腔用組成物。 3. The oral composition according to claim 1 , wherein component (C) is one or more anionic surfactants selected from acyl taurine having an acyl group of 8 to 18 carbon atoms and salts thereof . (C)成分が、ラウロイルメチルタウリンナトリウムである請求項記載の口腔用組成物。 4. The oral composition according to claim 3 , wherein component (C) is sodium lauroylmethyltaurate. 更に、(D)炭素数10以下の有機酸及びその塩から選ばれる1種又は2種以上を0.01~3質量%含有する請求項1~のいずれか1項記載の口腔用組成物。 5. The oral composition according to any one of claims 1 to 4 , further comprising (D) one or more selected from organic acids having 10 or less carbon atoms and salts thereof in an amount of 0.01 to 3% by mass. . (D)成分が、炭素数10以下のヒドロキシ酸及びその塩から選ばれる1種又は2種以上のものである請求項5記載の口腔用組成物。6. The oral composition according to claim 5, wherein component (D) is one or more selected from hydroxy acids having 10 or less carbon atoms and salts thereof. (A)銅イオンを0.005~0.1質量%、(A) 0.005 to 0.1% by mass of copper ions,
(B)イソプロピルメチルフェノールを0.01~1質量%、(B) 0.01 to 1% by mass of isopropylmethylphenol,
(C’)アシルアミノ酸及びその塩から選ばれる1種又は2種以上のアニオン性界面活性剤を0.3~1.5質量%、並びに(C') 0.3 to 1.5% by mass of one or more anionic surfactants selected from acylamino acids and salts thereof, and
(D’)炭素数10以下のヒドロキシ酸及びその塩から選ばれる1種又は2種以上を0.01~3質量%(D') 0.01 to 3% by mass of one or more selected from hydroxy acids having 10 or less carbon atoms and salts thereof
含有し、銅イオン源が、グルコン酸銅、クエン酸銅、硫酸銅及び塩化銅から選ばれる1種又は2種以上の水溶性銅化合物である口腔用組成物。and a copper ion source comprising one or more water-soluble copper compounds selected from copper gluconate, copper citrate, copper sulfate and copper chloride.
シリカ系研磨剤含有の練歯磨剤組成物である請求項1~7のいずれか1項記載の口腔用組成物。 The oral composition according to any one of claims 1 to 7, which is a toothpaste composition containing a silica-based abrasive. 口臭抑制及び口腔バイオフィルム殺菌用である請求項1~8のいずれか1項記載の口腔用組成物。 The oral composition according to any one of claims 1 to 8, which is used for suppressing bad breath and sterilizing oral biofilms.
JP2020522204A 2018-05-29 2019-05-28 oral composition Active JP7298601B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018102440 2018-05-29
JP2018102440 2018-05-29
PCT/JP2019/021053 WO2019230707A1 (en) 2018-05-29 2019-05-28 Composition for oral cavity

Publications (2)

Publication Number Publication Date
JPWO2019230707A1 JPWO2019230707A1 (en) 2021-06-24
JP7298601B2 true JP7298601B2 (en) 2023-06-27

Family

ID=68698187

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020522204A Active JP7298601B2 (en) 2018-05-29 2019-05-28 oral composition

Country Status (4)

Country Link
JP (1) JP7298601B2 (en)
KR (1) KR20210014618A (en)
CN (1) CN111867550B (en)
WO (1) WO2019230707A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000159647A (en) 1998-11-27 2000-06-13 Lion Corp Dentifrice composition
JP2003192555A (en) 2001-12-25 2003-07-09 Lion Corp Dentifrice composition
JP2004167218A (en) 2002-10-28 2004-06-17 Takasago Internatl Corp Deodorant composition
JP2008150305A (en) 2006-12-15 2008-07-03 Lion Corp Liquid composition for oral cavity

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60222130A (en) * 1984-04-20 1985-11-06 Lion Corp Deodorant
JP2540892B2 (en) * 1987-12-11 1996-10-09 ライオン株式会社 Oral composition
JP2540892Y2 (en) 1991-03-08 1997-07-09 オリンパス光学工業株式会社 Core stocker
JPH07165544A (en) * 1993-12-14 1995-06-27 Lion Corp Composition for oral cavity
JPH0925221A (en) * 1995-07-12 1997-01-28 Lion Corp Fur-removing agent
JP2000319152A (en) * 1999-05-12 2000-11-21 Lion Corp Dentifrice composition
JP2001089346A (en) * 1999-09-24 2001-04-03 We'll Corporation:Kk Composition for oral cavity
JP2003231621A (en) * 2002-02-06 2003-08-19 Lion Corp Composition for oral cavity for preventing foul breath
JP4957882B2 (en) * 2005-10-17 2012-06-20 ライオン株式会社 Ethanol-free mouthwash composition
WO2007148551A1 (en) * 2006-06-23 2007-12-27 Lion Corporation Liquid oral composition containing isopropylmethylphenol
JP5359546B2 (en) * 2009-05-20 2013-12-04 ライオン株式会社 Liquid oral composition
JP5493731B2 (en) 2009-11-06 2014-05-14 ライオン株式会社 Dentifrice composition
JP5573111B2 (en) * 2009-11-06 2014-08-20 ライオン株式会社 Isopropylmethylphenol-containing liquid oral composition
JP2011105650A (en) * 2009-11-18 2011-06-02 Lion Corp Gel composition for oral cavity
CN103974688A (en) * 2011-12-15 2014-08-06 高露洁-棕榄公司 Oral care compositions
WO2016093279A1 (en) * 2014-12-12 2016-06-16 ライオン株式会社 Composition for use in oral cavity
JP6413815B2 (en) * 2015-02-06 2018-10-31 ライオン株式会社 Liquid oral composition
JP6894668B2 (en) * 2016-03-31 2021-06-30 小林製薬株式会社 Oral composition
JP6756156B2 (en) * 2016-05-30 2020-09-16 ライオン株式会社 Oral composition
JP6659465B2 (en) * 2016-05-31 2020-03-04 花王株式会社 Oral composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000159647A (en) 1998-11-27 2000-06-13 Lion Corp Dentifrice composition
JP2003192555A (en) 2001-12-25 2003-07-09 Lion Corp Dentifrice composition
JP2004167218A (en) 2002-10-28 2004-06-17 Takasago Internatl Corp Deodorant composition
JP2008150305A (en) 2006-12-15 2008-07-03 Lion Corp Liquid composition for oral cavity

Also Published As

Publication number Publication date
KR20210014618A (en) 2021-02-09
CN111867550B (en) 2023-04-14
WO2019230707A1 (en) 2019-12-05
JPWO2019230707A1 (en) 2021-06-24
CN111867550A (en) 2020-10-30

Similar Documents

Publication Publication Date Title
JP7167938B2 (en) Oral biofilm formation inhibitor and oral composition
JP2017222720A (en) Composition for oral cavity
JP5552725B2 (en) Oral composition and oral biofilm disinfectant
JPWO2007148551A1 (en) Isopropylmethylphenol-containing liquid oral composition
JP2010143889A (en) Liquid composition for oral cavity
JP2009256228A (en) Liquid composition for oral cavity
JP2009149535A (en) Oral composition
JP2011098918A (en) Dentifrice composition
JP5493731B2 (en) Dentifrice composition
JP4873154B2 (en) Liquid oral composition
CN107205899B (en) Liquid oral composition
JP2008156288A (en) Composition for oral cavity
JP2005047855A (en) Oral cavity biofilm inhibitor and composition for oral cavity
JP7298601B2 (en) oral composition
KR102651630B1 (en) Dentistry composition
JP5600872B2 (en) Toothpaste composition
JP2008150305A (en) Liquid composition for oral cavity
JP2017007993A (en) Oral cavity composition and oral cavity biofilm fungicide
JP2006124315A (en) Oral composition
JP2017007991A (en) Composition for oral cavity and method for improving bactericidal activity of hinokitiol in the composition
JP2005187377A (en) Oral cavity biofilm inhibitory composition
JP4561973B2 (en) Dentifrice composition
JP2011126785A (en) Composition for oral cavity
JP5471318B2 (en) Dentifrice composition
WO2023100799A1 (en) Dentifrice composition

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220303

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221129

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230127

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230327

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230516

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230529

R150 Certificate of patent or registration of utility model

Ref document number: 7298601

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150